美国NDC复合药物数据库文件

药品名称：商品名称：药品NDC：报告期内： -格式:2020-5-3
NDC包装id：市场分类：活性成分：持证企业：

美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)

药品名称(分析)

商品名

药品NDC

专利人(分析)

报告期内

活性成分

市场分类

规格(分析)

NDC包装id

Anastrozole

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

6 mg

70168-0410-1

Estradiol

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

6 mg

70168-2010-1

Progesterone

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg

70168-3020-1

Testosterone

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

200 mg

70168-0121-1

Testosterone

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

12.5 mg

70168-0011-1

Diltiazem HCl 125 mg in 100 mL

HUMAN COMPOUNDED DRUG

60652-6015

SSM Health Care St. Louis d/b/a SSM Health St. Clare-Fenton

2024-1

DILTIAZEM HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

60652-6015-1

Phenylephrine Hydrochloride

HUMAN COMPOUNDED DRUG

60652-0104

SSM Health Care St. Louis d/b/a SSM Health St. Clare-Fenton

2024-1

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.1 mg/1 mL

60652-0104-1

Fentanyl/Ropivacaine

HUMAN COMPOUNDED DRUG

60652-4272

SSM Health Care St. Louis d/b/a SSM Health St. Clare-Fenton

2024-1

ROPIVACAINE HYDROCHLORIDE; FENTANYL CITRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

2 mg/1 mL; .002 mg/1 mL

60652-4272-1

C-Testosterone 87.5mg Pellet

HUMAN COMPOUNDED DRUG

72682-8587

AnazaoHealth Corporation

2023-2

TESTOSTERONE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mg

72682-8587-1

Succinylcholine Chloride

HUMAN COMPOUNDED DRUG

60652-7536

SSM Health Care St. Louis d/b/a SSM Health St. Clare-Fenton

2024-2

SUCCINYLCHOLINE CHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

20 mg/1 mL

60652-7536-1

Oxytocin

HUMAN COMPOUNDED DRUG

60652-0903

SSM Health Care St. Louis d/b/a SSM Health St. Clare-Fenton

2024-2

OXYTOCIN

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.06 U/1 mL

60652-0903-1

Fentanyl Citrate Drip

HUMAN COMPOUNDED DRUG

60652-6030

SSM Health Care St. Louis d/b/a SSM Health St. Clare-Fenton

2024-2

FENTANYL CITRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.05 mg/1 mL

60652-6030-1

Neostigmine methylsulfate

HUMAN COMPOUNDED DRUG

60652-0329

SSM Health Care St. Louis d/b/a SSM Health St. Clare-Fenton

2024-2

NEOSTIGMINE METHYLSULFATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

60652-0329-1

Diltiazem HCl 125 mg in 100 mL

HUMAN COMPOUNDED DRUG

60652-6015

SSM Health Care St. Louis d/b/a SSM Health St. Clare-Fenton

2024-2

DILTIAZEM HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

60652-6015-1

Phenylephrine Hydrochloride

HUMAN COMPOUNDED DRUG

60652-0104

SSM Health Care St. Louis d/b/a SSM Health St. Clare-Fenton

2024-2

PHENYLEPHRINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.1 mg/1 mL

60652-0104-1

141070 HYDROCORTISONE 1% / HYDROQUINONE 8% / TRETINOIN 0.05%

HUMAN COMPOUNDED DRUG

72934-6393

SKNV

2024-1

HYDROCORTISONE; HYDROQUINONE; TRETINOIN

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 g/100 mL; 8 g/100 mL; .05 g/100 mL

72934-6393-2

011216 CLINDAMYCIN 1% / NIACINAMIDE 4% / SPIRONOLACTONE 2% / TRETINOIN 0.025% Gel

HUMAN COMPOUNDED DRUG

72934-1313

SKNV

2024-1

CLINDAMYCIN PHOSPHATE; NIACINAMIDE; SPIRONOLACTONE; TRETINOIN

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 g/100 mL; 4 g/100 mL; 2 g/100 mL; .025 g/100 mL

72934-1313-2

Maintenance 4 to1 Low K (20 mEq) 810ml Bag

HUMAN COMPOUNDED DRUG

71285-0103

Central Admixture Pharmacy Services, Inc.

2024-1

CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE; SODIUM CHLORIDE; TROMETHAMINE; POTASSIUM CHLORIDE; DEXTROSE MONOHYDRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1.635 g/810 mL; 13.15 g/810 mL; 1.11 g/810 mL; 23.2 g/810 mL; 18.8 meq/810 mL; 7.2 g/810 mL; 20 meq/810 mL; 49.45 g/810 mL

71285-0103-1

Maintenance 8 to1 Low K (36 mEq) LOW DEXTROSE 500ml Bag

HUMAN COMPOUNDED DRUG

71285-0108

Central Admixture Pharmacy Services, Inc.

2024-1

SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; ANHYDROUS DEXTROSE; CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; SODIUM CHLORIDE; TROMETHAMINE; POTASSIUM CHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.70152 g/500 mL; 14.6624 g/500 mL; 1.03332 g/500 mL; 8.3108 g/500 mL; 12.4 meq/500 mL; 4.05 g/500 mL; 36 meq/500 mL

71285-0108-1

Maintenance 4 to1 Low K (40 mEq) In Plasmalyte A, ph 7.4 with Tromethamine

HUMAN COMPOUNDED DRUG

71285-0112

Central Admixture Pharmacy Services, Inc.

2024-1

TROMETHAMINE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM GLUCONATE; MAGNESIUM CHLORIDE; SODIUM ACETATE; POTASSIUM CHLORIDE; MANNITOL; MAGNESIUM SULFATE HEPTAHYDRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

4.536 g/1000 mL; 12.53 g/1000 mL; 4.1028 g/1000 mL; 3.9156 g/1000 mL; .234 g/1000 mL; 2.8704 g/1000 mL; 3.2686 g/1000 mL; 7 g/1000 mL; 40.6 meq/1000 mL

71285-0112-1

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：